Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?

Clinical and Experimental Rheumatology

Volumn 25, Issue 4 SUPPL. 45, 2007, Pages

  Pay, Salih ^a   Abbasov, Tarlan ^a   Erdem, Hakan ^a   Musabak, Ugur ^a   Simsek, Ismail ^a   Pekel, Aysel ^a   Akdogan, Ali ^b   Sengul, Ali ^a   Dinc, Ayhan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aneurysm; Beh et's disease; Leeds activity score; MMP 2; MMP 9

Indexed keywords

GELATINASE A; GELATINASE B; BIOLOGICAL MARKER;

ABDOMINAL AORTA ANEURYSM; ADULT; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SKIN DISEASE; SYSTEMIC DISEASE; THROMBOSIS; VASCULITIS; ANEURYSM; LEEDS ACTIVITY SCORE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VASCULAR DISEASE;

ADULT; ANEURYSM; BEHCET SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; SEVERITY OF ILLNESS INDEX; VASCULITIS;

EID: 35448929936     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. KOC Y, GULLU I, AKPEK G et al.: Vascular involvement in BD. J Rheumatol 1992; 19: 402-10.
2. CALAMIA KT, SCHIRMER M, MELIKOGLU M: Major vessel involvement in Behçet's disease. Curr Opin Rheumatol 2004; 17: 1-8.
3. SHERIF A, STEWART P, MENDES DM: The repetitive vascular catastrophes of Behçet's disease. A case report with review of the literature. Ann Vasc Surg 1992; 6: 85-9.
4. HAMURYUDAN V, YURADAKUL S, MORAL F et al.: Pulmonary arterial aneurysms in Behçet's syndrome: A report of 24 cases. Br J Rheumatol 1994; 33: 48-51.
5. CORBEL M, BELLEGUIC C, BOICHOT E, LAGENTE V: Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 2002; 18: 51-61.
6. KATSUDA S, OKADA Y, OKADA Y, IMAI K, NAKANISHI I: Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am J Pathol 1994; 145: 1208-18.
7. OKADA Y, MORODOMI T, ENGHILD JJ et al.: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990; 194: 721-30.
8. THOMPSON RW, PARKS WC: Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 1996; 800: 157-74.
9. KADOGLOU NP, LIAPIS CC: Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysm. Curr Med Res Opin 2004; 20: 419-32.
10. KEELING WB, ARMSTRONG PA, STONE PA, BANDYK DE SHAMES ML: An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 2005; 39: 457-64.
11. TAKESHITA S, TOKUTOMI T, KAWASE H et al.: Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol 2001 125: 340-4.
12. SENZAKI H, MASUTANI S, KOBAYASHI J et al.: Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001;104: 860-3.
13. GAVIN PJ, CRAWFORD SE, SHULMAN ST, GARCIA FL, ROWLEY AH: Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 2003; 23:576-81
14. CHUA PK, MELISH ME, YU Q, YANAGIHARA R, YAMAMOTO KS, NERURKAR VR: Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 2003; 10: 308-14.
15. NIKKARI ST, HOYHTYA M, ISOLA J, NIKKARI T: Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996; 149: 1427-33.
16. SORBI D, FRENCH DL, NUOVO GJ, KEW RR, ARBEIT LA, GRUBER BL: Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996; 39: 1747-53.
17. MATSUYAMAA, SAKAI N, ISHIGAMI M et al.: Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003; 108: 1469-73.
18. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
19. BHAKTA BB, BRENNAN P, JAMES T, CHAMBERLEIN MA, NOBLE BA, SILMAN AJ: Behçet's Disease: Evaluation of a new instrument to measure clinical activity. Rheumatology 1999; 38: 728-33.
20. LE THI HUONG D, WECHSLER B, PAPO T et al.: Arterial lesions in Behçet's disease. J Rheumatol 1995; 22: 2103-13.
21. HAMURYUDAN V, ÖZ B, TÚZÚN H, YAZICI H: The menacing pulmonary artery aneurysms of Behçet's syndrome. Clin Exp Rheumatol 2004; 22(Suppl. 34): S1-S3.
22. ÖZEREN M, DOǦAN OV, DOǦAN S e t al.: True and pseudo aneursyms of coronary arteries in a patients with Behçet's disease. Eur J Cardiothorac Surg 2004; 25: 465-7.
23. PAPALAMBROS E, SIGALA F, GEORGOPOULOS S et al.: Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: Correlation with symptoms and aortic diameter. Int J Mol Med 2003;12: 965-8.
24. NISHIMURA K, IKEBUCHI M, KANAOKA Y et al.: Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Int Angiol 2003; 22: 229-38.
25. JONES GT, PHILLIPS VL, HARRIS EL, ROSSAAK JI, VAN RIJ AM: Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003 38: 1363-7.
26. PAY S, ERDEM H, SERDAR M, DINÇ A, SIMSEK I, TURAN M: Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: Is there any difference between rheumatoid arthritis, Behçet's disease and familial Mediterranean rever? Clin Rheumatol 2002; 21: 511-5.
27. PAY S, ERDEM H, PEKEL A, SIMSEK I, MUSABAK U, SENGUL A, DINC A: Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1β play a major role in Behçet's synovitis? Rheumatol Int 2006; 26: 608-13.